Corosolic acid induces apoptotic cell death in HCT116 human colon cancer cells through a caspase-dependent pathway

International Journal of Molecular Medicine

Volumn 33, Issue 4, 2014, Pages 943-949

  Sung, Bokyung ^a   Kang, Yong Jung ^a   Kim, Dong Hwan ^a   Hwang, Seong Yeon ^a   Lee, Yujin ^a   Kim, Minjeong ^a   Yoon, Jeong Hyun ^a   Kim, Cheol Min ^a,b   Chung, Hae Young ^a   Kim, Nam Deuk ^a  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Apoptosis; Caspase; Colorectal cancer cells; Corosolic acid

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; COROSOLIC ACID; FAS ANTIGEN; FAS LIGAND; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PENTACYCLIC TRITERPENE; PHOSPHATIDYLSERINE; PROCASPASE 3; PROCASPASE 8; PROCASPASE 9; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CELL VIABILITY; CHROMATIN CONDENSATION; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; HCT116 CELL LINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; UPREGULATION;

APOPTOSIS; CASPASES; CELL CYCLE PROTEINS; CELL SHAPE; CELL SURVIVAL; CHROMATIN; COLONIC NEOPLASMS; ENZYME ACTIVATION; G1 PHASE; HCT116 CELLS; HUMANS; SIGNAL TRANSDUCTION; TRITERPENES;

EID: 84899517183     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1639     Document Type: Article

References (40)

1. Bray F, Jemal A, Grey N, Ferlay J and Forman D: Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 13: 790-801, 2012.
2. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG and Lee JS: Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 45: 1-14, 2013.
3. Kanwar SS, Poolla A and Majumdar AP: Regulation of colon cancer recurrence and development of therapeutic strategies. World J Gastrointest Pathophysiol 3: 1-9, 2012.
4. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
5. Lowe SW and Lin AW: Apoptosis in cancer. Carcinogenesis 21: 485-495, 2000. (Pubitemid 30137934)
6. Newman DJ, Cragg GM and Snader KM: Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66: 1022-1037, 2003. (Pubitemid 36909859)
7. Ahn KS, Hahm MS, Park EJ, Lee HK and Kim IH: Corosolic acid isolated from the fruit of Crataegus pinnatifida var. psilosa is a protein kinase C inhibitor as well as a cytotoxic agent. Planta Med 64: 468-470, 1998. (Pubitemid 28298708)
8. Li B, Meng X, Zhu L, Jiao X and Zhang J: Application of high-speed counter-current chromatography for isolation of triterpenes from Schisandra chinensis (Turcz.) Baill and induction apoptosis mechanism of HSC-T6. Biomed Mater Eng 24: 969-977, 2013.
9. Uto T, Sakamoto A, Tung NH, et al: Anti-proliferative activities and apoptosis induction by triterpenes derived from Eriobotrya japonica in human leukemia cell lines. Int J Mol Sci 14: 4106-4120, 2013.
10. Miura T, Takagi S and Ishida T: Management of diabetes and its complications with banaba (Lagerstroemia speciosa L.) and corosolic acid. Evid Based Complement Alternat Med 2012: 871495, 2012.
11. Caligiani A, Malavasi G, Palla G, Marseglia A, Tognolini M and Bruni R: A simple GC-MS method for the screening of betulinic, corosolic, maslinic, oleanolic and ursolic acid contents in commercial botanicals used as food supplement ingredients. Food Chem 136: 735-741, 2013.
12. Lee MS, Lee CM, Cha EY, et al: Activation of AMP-activated protein kinase on human gastric cancer cells by apoptosis induced by corosolic acid isolated from Weigela subsessilis. Phytother Res 24: 1857-1861, 2010.
13. Rao AR, Veeresham C and Asres K: In vitro and in vivo inhibitory activities of four Indian medicinal plant extracts and their major components on rat aldose reductase and generation of advanced glycation endproducts. Phytother Res 27: 753-760, 2013.
14. Yin MC, Lin MC, Mong MC and Lin CY: Bioavailability, distribution, and antioxidative effects of selected triterpenes in mice. J Agric Food Chem 60: 7697-7701, 2012
15. Chen H, Yang J, Zhang Q, Chen LH and Wang Q: Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-êB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression. Circ J 76: 995-1003, 2012.
16. Takagi S, Miura T, Ishihara E, Ishida T and Chinzei Y: Effect of corosolic acid on dietary hypercholesterolemia and hepatic steatosis in KK-Ay diabetic mice. Biomed Res 31: 213-218, 2010.
17. Klein G, Kim J, Himmeldirk K, Cao Y and Chen X: Antidiabetes and anti-obesity activity of Lagerstroemia speciosa. Evid Based Complement Alternat Med 4: 401-407, 2007.
18. Aguirre MC, Delporte C, Backhouse N, et al: Topical anti-inflammatory activity of 2alpha-hydroxy pentacyclic triterpene acids from the leaves of Ugni molinae. Bioorg Med Chem 14: 5673-5677, 2006. (Pubitemid 43994463)
19. Nho KJ, Chun JM and Kim HK: Corosolic acid induces apoptotic cell death in human lung adenocarcinoma A549 cells in vitro. Food Chem Toxicol 56: 8-17, 2013.
20. Horlad H, Fujiwara Y, Takemura K, et al: Corosolic acid impairs tumor development and lung metastasis by inhibiting the immunosuppressive activity of myeloid-derived suppressor cells. Mol Nutr Food Res 57: 1046-1054, 2013.
21. Cai X, Zhang H, Tong D, et al: Corosolic acid triggers mitochondria and caspase-dependent apoptotic cell death in osteosarcoma MG-63 cells. Phytother Res: Feb 21, 2011 (Epub ahead of print).
22. Fujiwara Y, Komohara Y, Ikeda T and Takeya M: Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages. Cancer Sci 102: 206-211, 2011.
23. Xu Y, Ge R, Du J, et al: Corosolic acid induces apoptosis through mitochondrial pathway and caspase activation in human cervix adenocarcinoma HeLa cells. Cancer Lett 284: 229-237, 2009.
24. Lee MS, Cha EY, Thuong PT, Kim JY, Ahn MS and Sul JY: Down-regulation of human epidermal growth factor receptor 2/neu oncogene by corosolic acid induces cell cycle arrest and apoptosis in NCI-N87 human gastric cancer cells. Biol Pharm Bull 33: 931-937, 2010.
25. Miura T, Itoh Y, Kaneko T, et al: Corosolic acid induces GLUT4 translocation in genetically type 2 diabetic mice. Biol Pharm Bull 27: 1103-1105, 2004. (Pubitemid 41701767)
26. Wen X, Xia J, Cheng K, et al: Pentacyclic triterpenes. Part 5: synthesis and SAR study of corosolic acid derivatives as inhibitors of glycogen phosphorylases. Bioorg Med Chem Lett 17: 5777-5782, 2007. (Pubitemid 47446231)
27. Shi L, Zhang W, Zhou YY, et al: Corosolic acid stimulates glucose uptake via enhancing insulin receptor phosphorylation. Eur J Pharmacol 584: 21-29, 2008.
28. Vermeulen K, Berneman ZN and Van Bockstaele DR: Cell cycle and apoptosis. Cell Prolif 36: 165-175, 2003. (Pubitemid 36808272)
29. Weitz J, Koch M, Debus J, Höhler T, Galle PR and Buchler MW: Colorectal cancer. Lancet 365: 153-165, 2005. (Pubitemid 40091806)
30. Mazumder K, Tanaka K and Fukase K: Cytotoxic activity of ursolic acid derivatives obtained by isolation and oxidative derivatization. Molecules 18: 8929-8944, 2013.
31. Chang HY and Yang X: Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev 64: 821-846, 2000. (Pubitemid 32475932)
32. Kischkel FC, Hellbardt S, Behrmann I, et al: Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14: 5579-5588, 1995.
33. Li Y, Xing D, Chen Q and Chen WR: Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid. Int J Cancer 127: 462-473, 2010.
34. Hsu YL, Kuo PL and Lin CC: The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. Life Sci 75: 1231-1242, 2004.
35. Kim JS, Joo EJ, Chun J, et al: Induction of apoptosis by ginsenoside Rk1 in SK-MEL-2-human melanoma. Arch Pharm Res 35: 717-722, 2012.
36. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
37. Mizutani Y, Hongo F, Sato N, Ogawa O, Yoshida O and Miki T: Significance of serum soluble Fas ligand in patients with bladder carcinoma. Cancer 92: 287-293, 2001. (Pubitemid 32664434)
38. Osorio LM, Aguilar-Santelises M, De Santiago A, Hachiya T, Mellstedt H and Jondal M: Increased serum levels of soluble Fas in progressive B-CLL. Eur J Haematol 66: 342-346, 2001. (Pubitemid 32552170)
39. Khong HT and Restifo NP: Natural selection of tumor variants in the generation of 'tumor escape' phenotypes. Nat Immunol 3: 999-1005, 2002. (Pubitemid 35363649)
40. Zhu Q, Liu JY, Yang CM, et al: Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells. Eur J Gastroenterol Hepatol 18: 1071-1077, 2006. (Pubitemid 44379360)